Drug Shortage Report for SODIUM THIOSULFATE INJECTION USP
Report ID | 79024 |
Drug Identification Number | 02137186 |
Brand name | SODIUM THIOSULFATE INJECTION USP |
Common or Proper name | Sodium |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM THIOSULFATE |
Strength(s) | 25% |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10mL Glass vial |
ATC code | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-09-09 |
Estimated end date | |
Actual end date | 2020-02-03 |
Shortage status | Resolved |
Updated date | 2020-02-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2020-01-29 | French | Compare |
v22 | 2020-02-03 | English | Compare |
v23 | 2020-02-03 | French | Compare |
v24 | 2020-02-04 | English | Compare |